» Articles » PMID: 29263701

Low Expression of GATA3 Promotes Cell Proliferation and Metastasis in Gastric Cancer

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2017 Dec 22
PMID 29263701
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

GATA3, a member of the GATA zinc finger transcription factor family, has been widely investigated for its role in cancer. Although a recent report has found that GATA3 is downregulated in gastric cancer (GC), the detailed mechanism of GATA3 in GC is still unknown. Here, we investigated whether GATA3 was downregulated in GC patients' tissue samples and cell lines using quantitative real time polymerase chain reaction and Western blotting. In addition, we conducted several functional experiments to investigate the effect of GATA3 in GC, including cell proliferation, metastasis and epithelial-mesenchymal transition (EMT). The results showed that GATA3 was downregulated in GC tissue samples and cells. Moreover, the expression of GATA3 was associated with tumor size, stage and metastasis. Restoration of GATA3 levels suppressed GC cell proliferation, migration and invasion. Furthermore, chromatin immunoprecipitation and luciferase reporter assay also revealed that GATA3 transcriptionally regulated ZEB1, thereby suppressing EMT. All these findings suggest that GATA3 serves as an oncogene in GC development.

Citing Articles

The plasticity of epithelial cells and its potential in the induced differentiation of gastric cancer.

Yan Z, Liu Y, Yuan Y Cell Death Discov. 2024; 10(1):512.

PMID: 39719478 PMC: 11668900. DOI: 10.1038/s41420-024-02275-x.


miRNAs Involvement in Modulating Signalling Pathways Involved in Ros-Mediated Oxidative Stress in Melanoma.

Escobar Moreno J, Fajardo Castiblanco J, Riano Rodriguez L, Barrios Ospina P, Zabala Bello C, Munoz Roa E Antioxidants (Basel). 2024; 13(11).

PMID: 39594467 PMC: 11591318. DOI: 10.3390/antiox13111326.


A transcription factor that promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of ovarian cancer cells and its possible mechanisms.

Qi Y, Mo K, Zhang T Biomed Eng Online. 2021; 20(1):83.

PMID: 34399777 PMC: 8366031. DOI: 10.1186/s12938-021-00919-y.


GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression.

Zhang Z, Fang X, Xie G, Zhu J Oncol Lett. 2021; 21(3):231.

PMID: 33613720 PMC: 7856699. DOI: 10.3892/ol.2021.12492.


FMNL1 Exhibits Pro-Metastatic Activity CXCR2 in Clear Cell Renal Cell Carcinoma.

Zhang M, Li Q, Yang Y, Cao Y, Zhang C Front Oncol. 2020; 10:564614.

PMID: 33324547 PMC: 7726248. DOI: 10.3389/fonc.2020.564614.


References
1.
Martinelli P, Pau E, Cox T, Sainz Jr B, Dusetti N, Greenhalf W . GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut. 2016; 66(9):1665-1676. PMC: 5070637. DOI: 10.1136/gutjnl-2015-311256. View

2.
de Guzman Strong C, Wertz P, Wang C, Yang F, Meltzer P, Andl T . Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3. J Cell Biol. 2006; 175(4):661-70. PMC: 2064601. DOI: 10.1083/jcb.200605057. View

3.
Takaku M, Grimm S, Wade P . GATA3 in Breast Cancer: Tumor Suppressor or Oncogene?. Gene Expr. 2015; 16(4):163-8. PMC: 4758516. DOI: 10.3727/105221615X14399878166113. View

4.
Zheng R, Blobel G . GATA Transcription Factors and Cancer. Genes Cancer. 2011; 1(12):1178-88. PMC: 3092280. DOI: 10.1177/1947601911404223. View

5.
Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T . The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer. J Ovarian Res. 2014; 7:76. PMC: 4127950. DOI: 10.1186/1757-2215-7-76. View